NTLA ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Intellia Therapeutics, Inc. investment
Portfolio Pulse from
Levi & Korsinsky has started an investigation into Intellia Therapeutics, Inc. for potential violations of federal securities laws. This follows a press release by Intellia on January 9, 2025, outlining its strategic priorities and anticipated milestones for 2025.
January 20, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Levi & Korsinsky is investigating Intellia Therapeutics for possible federal securities law violations. This could impact investor confidence and stock price.
The investigation by Levi & Korsinsky into Intellia Therapeutics for potential securities law violations could lead to legal challenges or penalties, affecting investor confidence and potentially causing a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100